Summary for Patients: Comparison of Patients Infected With Delta Versus Omicron COVID-19 Variants Presenting to Paris Emergency Departments.
出版信息
Ann Intern Med. 2022 Jun;175(6):I32. doi: 10.7326/P22-0005. Epub 2022 Mar 15.
Abstract
摘要
相似文献
1
Summary for Patients: Comparison of Patients Infected With Delta Versus Omicron COVID-19 Variants Presenting to Paris Emergency Departments.患者总结：巴黎急诊科收治的感染新冠病毒德尔塔变异株与奥密克戎变异株患者的比较
Ann Intern Med. 2022 Jun;175(6):I32. doi: 10.7326/P22-0005. Epub 2022 Mar 15.
2
Comparison of Patients Infected With Delta Versus Omicron COVID-19 Variants Presenting to Paris Emergency Departments : A Retrospective Cohort Study.德尔塔变异株与奥密克戎变异株感染患者在巴黎急诊科就诊的比较：一项回顾性队列研究。
Ann Intern Med. 2022 Jun;175(6):831-837. doi: 10.7326/M22-0308. Epub 2022 Mar 15.
3
Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.2021 年 7 月 15 日至 9 月 23 日和 2021 年 12 月 21 日至 2022 年 1 月 27 日期间，加利福尼亚州一家医院因实验室确诊的 SARS-CoV-2 感染住院的成年人的临床特征和结局，期间 B.1.617.2（德尔塔）和 B.1.1.529（奥密克戎）变异株占主导地位。
MMWR Morb Mortal Wkly Rep. 2022 Feb 11;71(6):217-223. doi: 10.15585/mmwr.mm7106e2.
4
Genomic Surveillance for SARS-CoV-2 Variants: Predominance of the Delta (B.1.617.2) and Omicron (B.1.1.529) Variants - United States, June 2021-January 2022.SARS-CoV-2 变体的基因组监测：Delta（B.1.617.2）和奥密克戎（B.1.1.529）变体占主导地位-美国，2021 年 6 月-2022 年 1 月。
MMWR Morb Mortal Wkly Rep. 2022 Feb 11;71(6):206-211. doi: 10.15585/mmwr.mm7106a4.
5
Impact of the outbreak of SARS-CoV-2 infection on urgent gynecological care.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染爆发对紧急妇科护理的影响。
J Gynecol Obstet Hum Reprod. 2020 Oct;49(8):101841. doi: 10.1016/j.jogoh.2020.101841. Epub 2020 Jun 23.
6
Pathogenicity of SARS-CoV-2 Omicron (R346K) variant in Syrian hamsters and its cross-neutralization with different variants of concern.奥密克戎（R346K）变异株在叙利亚仓鼠中的致病性及其与不同关切变异株的交叉中和作用。
EBioMedicine. 2022 May;79:103997. doi: 10.1016/j.ebiom.2022.103997. Epub 2022 Apr 8.
7
Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein.SARS-CoV-2 的奥密克戎和德尔塔变体：刺突蛋白的比较计算研究。
J Med Virol. 2022 Apr;94(4):1641-1649. doi: 10.1002/jmv.27526. Epub 2021 Dec 27.
8
OraSure InteliSwab Rapid Antigen Test Performance with the SARS-CoV-2 Variants of Concern-Alpha, Beta, Gamma, Delta, and Omicron.OraSure InteliSwab 快速抗原检测在关注变异株 Alpha、Beta、Gamma、Delta 和奥密克戎时的性能。
Viruses. 2022 Mar 6;14(3):543. doi: 10.3390/v14030543.
9
Viral epidemiology and SARS-CoV-2 co-infections with other respiratory viruses during the first COVID-19 wave in Paris, France.法国巴黎首次 COVID-19 浪潮期间的病毒流行病学和 SARS-CoV-2 与其他呼吸道病毒的合并感染。
Influenza Other Respir Viruses. 2021 Jul;15(4):425-428. doi: 10.1111/irv.12853. Epub 2021 Apr 4.
10
Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022.mRNA 疫苗对 COVID-19 相关急诊科和紧急护理就诊以及成人住院的 2 剂和 3 剂效力下降在德尔塔和奥密克戎变异主导期间 - VISION 网络，10 个州，2021 年 8 月至 2022 年 1 月。
MMWR Morb Mortal Wkly Rep. 2022 Feb 18;71(7):255-263. doi: 10.15585/mmwr.mm7107e2.
引用本文的文献
1
Duration of protection of CoronaVac plus heterologous BNT162b2 booster in the Omicron period in Brazil.科兴疫苗加强针与辉瑞-BioNTech 异源疫苗对奥密克戎变异株的保护效力持续时间：巴西研究
Nat Commun. 2022 Jul 18;13(1):4154. doi: 10.1038/s41467-022-31839-7.
2
Outcome of very high-risk patients treated by Sotrovimab for mild-to-moderate COVID-19 Omicron, a prospective cohort study (the ANRS 0003S COCOPREV study).索托维单抗治疗轻至中度新冠病毒奥密克戎变异株感染的极高风险患者的结局：一项前瞻性队列研究（法国国家艾滋病研究机构0003S COCOPREV研究）
J Infect. 2022 Jun;84(6):e101-e104. doi: 10.1016/j.jinf.2022.04.010. Epub 2022 Apr 7.
Zotero 插件